159O Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the PARADIGM study group

Vincent M. T. de Jong, Y. Wang, Mark Opdam, ND ter Hoeve, Katarzyna Jóźwiak, Michael Hauptmann, Nikolas Stathonikos, Hugo M. Horlings, Annegien Broeks, Stefan Michiels, Elsken van der Wall, Paul van Diest, Sabine Siesling, Marjanka K. Schmidt, Shrushma Loi, M. Kok, Sabine C. Linn, Roberto Salgado, Gwen Dackus